ID

33713

Descripción

Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01092390

Link

https://clinicaltrials.gov/show/NCT01092390

Palabras clave

Versiones (1)
  1. 20/12/18 20/12/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01092390

Inglés

Eligibility Diabetes NCT01092390

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01092390
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants have a diagnosis of diabetes (either oral medication or diet controlled)
Descripción

Diabetes Mellitus | Oral medication | Dietary control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0175795
UMLS CUI [3]
C0743195
have an average systolic blood pressure (sbp) <150 and diastolic blood pressure (dbp) <90 mmhg
Descripción

Systolic Pressure Average | Diastolic blood pressure Average

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0871470
UMLS CUI [1,2]
C1510992
UMLS CUI [2,1]
C0428883
UMLS CUI [2,2]
C1510992
have quantified proteinuria -- urine albumin/creatinine ratio of > 17 mg/g (men) and >25 mg/g (women) (i.e. at least microalbuminuria).
Descripción

Proteinuria | Urine albumin/creatinine ratio measurement | Gender | Microalbuminuria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0033687
UMLS CUI [2]
C0455271
UMLS CUI [3]
C0079399
UMLS CUI [4]
C0730345
participants must be on stable doses of antihypertensive, hypoglycemic, and lipid lowering medications for a minimum of two months prior to randomization. participants must agree to stay on stable doses of diabetes, antihypertensive and lipid medication for the duration of the study.
Descripción

Antihypertensive Agents Dose Stable | Hypoglycemic Agents Dose Stable | Hypolipidemic Agents Dose Stable | Antidiabetics Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0020616
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0086440
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C0935929
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
major exclusion criteria will be poorly controlled diabetes (hemoglobin a1c >9%)
Descripción

Poorly controlled diabetes mellitus | Hemoglobin A1c measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0554876
UMLS CUI [2]
C0474680
use of insulin
Descripción

Insulin use

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0240016
use of fish oil supplements or are unwilling to stop fish oil supplements one month prior to randomization and refrain from the supplements during the study
Descripción

Fish Oil Supplements | Fish Oil Supplements Discontinue Unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0016157
UMLS CUI [1,2]
C0242295
UMLS CUI [2,1]
C0016157
UMLS CUI [2,2]
C0242295
UMLS CUI [2,3]
C1444662
UMLS CUI [2,4]
C0558080
stage 4 or stage 5 ckd or a screening urine protein/creatinine ratio of >2.5.
Descripción

Chronic kidney disease stage | Urine protein/creatinine ratio measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2074731
UMLS CUI [2]
C1096054
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01092390

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01092390
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus | Oral medication | Dietary control
Item
participants have a diagnosis of diabetes (either oral medication or diet controlled)
boolean
C0011849 (UMLS CUI [1])
C0175795 (UMLS CUI [2])
C0743195 (UMLS CUI [3])
Systolic Pressure Average | Diastolic blood pressure Average
Item
have an average systolic blood pressure (sbp) <150 and diastolic blood pressure (dbp) <90 mmhg
boolean
C0871470 (UMLS CUI [1,1])
C1510992 (UMLS CUI [1,2])
C0428883 (UMLS CUI [2,1])
C1510992 (UMLS CUI [2,2])
Proteinuria | Urine albumin/creatinine ratio measurement | Gender | Microalbuminuria
Item
have quantified proteinuria -- urine albumin/creatinine ratio of > 17 mg/g (men) and >25 mg/g (women) (i.e. at least microalbuminuria).
boolean
C0033687 (UMLS CUI [1])
C0455271 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0730345 (UMLS CUI [4])
Antihypertensive Agents Dose Stable | Hypoglycemic Agents Dose Stable | Hypolipidemic Agents Dose Stable | Antidiabetics Dose Stable
Item
participants must be on stable doses of antihypertensive, hypoglycemic, and lipid lowering medications for a minimum of two months prior to randomization. participants must agree to stay on stable doses of diabetes, antihypertensive and lipid medication for the duration of the study.
boolean
C0003364 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0020616 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0086440 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0935929 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Poorly controlled diabetes mellitus | Hemoglobin A1c measurement
Item
major exclusion criteria will be poorly controlled diabetes (hemoglobin a1c >9%)
boolean
C0554876 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
Insulin use
Item
use of insulin
boolean
C0240016 (UMLS CUI [1])
Fish Oil Supplements | Fish Oil Supplements Discontinue Unwilling
Item
use of fish oil supplements or are unwilling to stop fish oil supplements one month prior to randomization and refrain from the supplements during the study
boolean
C0016157 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0016157 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
Chronic kidney disease stage | Urine protein/creatinine ratio measurement
Item
stage 4 or stage 5 ckd or a screening urine protein/creatinine ratio of >2.5.
boolean
C2074731 (UMLS CUI [1])
C1096054 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial